Amelioration of physicochemical, pharmaceutical, and pharmacokinetic properties of lornoxicam by cocrystallization with a novel coformer

References

• Sugandha K, Kaity S, Mukherjee S, et al. Solubility enhancement of ezetimibe by a cocrystal engineering technique. Cryst Growth Des. 2014;14(9):4475–4486.
   Web of Science ®Google Scholar
• Pathak CD, Savjani KT, Gajjar AK, et al. An efficient approach to enhance solubility. Int J Pharm Pharm Sci. 2013;5:25–121.
   Google Scholar
• Yan Y, Chen J-M, Lu T-B. Simultaneously enhancing the solubility and permeability of acyclovir by crystal engineering approach. CrystEngComm. 2013;15(33):6457–6460.
   Web of Science ®Google Scholar
• Suresh K, Mannava MC, Nangia A. Cocrystals and alloys of nitazoxanide: enhanced pharmacokinetics. Chem Commun. 2016;52(22):4223–4226.
   PubMed Web of Science ®Google Scholar
• Shimpi MR, Childs SL, Boström D, et al. New cocrystals of ezetimibe with l-proline and imidazole. CrystEngComm. 2014;16(38):8984–8993.
   Web of Science ®Google Scholar
• Steed JW. The role of co-crystals in pharmaceutical design. Trends Pharmacol Sci. 2013;34(3):185–193.
   PubMed Web of Science ®Google Scholar
• Allam AN, Naggar VF, El Gamal SS. Formulation and physicochemical characterization of chitosan/acyclovir co-crystals. Pharm Dev Technol. 2013;18(4):856–865.
   PubMed Web of Science ®Google Scholar
• Shiraki K, Takata N, Takano R, et al. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds. Pharm Res. 2008;25(11):2581–2592.
   PubMed Web of Science ®Google Scholar
• Sun CC, Hou H. Improving mechanical properties of caffeine and methyl gallate crystals by cocrystallization. Cryst Growth Des. 2008;8(5):1575–1579.
   Web of Science ®Google Scholar
• Vinesh V, Sevukarajan M, Rajalakshmi R, et al. Enhancement of solubility of tadalafil by cocrystal approach. Int Res J Pharm. 2016;4(4):218–223.
   Google Scholar
• Chemate S, Chowdary K. A factorial study on enhancement of solubility and dissolution rate of lornoxicam employing hp-[beta]-cyclodextrin and surfactants. Int J Pharm Sci Res. 2012;3:2252.
   Google Scholar
• Sharma A, Jain C. Solid dispersion: a promising technique to enhance solubility of poorly water soluble drug. Int J Drug Deliv. 2011;3:149.
   Google Scholar
• Sanphui P, Goud NR, Khandavilli UR, et al. Fast dissolving curcumin cocrystals. Cryst Growth Des. 2011;11(9):4135–4145.
   Web of Science ®Google Scholar
• Nijhawan M, Santhosh A, Babu PS, et al. Solid state manipulation of lornoxicam for cocrystals-physicochemical characterization. Drug Dev Ind Pharm. 2014;40(9):1163–1172.
   PubMed Web of Science ®Google Scholar
• Gadade D, Kulkarni D, Rathi P, et al. Solubility enhancement of lornoxicam by crystal engineering. Indian J Pharm Sci. 2017;79:277–286.
   Web of Science ®Google Scholar
• Nikam VJ, Patil SB. Pharmaceutical cocrystals of nebivolol hydrochloride with enhanced solubility. J Cryst Growth. 2020;534:125488.
   Web of Science ®Google Scholar
• Abbas N, Latif S, Afzal H, et al. Simultaneously improving mechanical, formulation, and in vivo performance of naproxen by co-crystallization. AAPS PharmSciTech. 2018;19(7):3249–3257.
   PubMed Web of Science ®Google Scholar
• Thenge RR, Patond V, Ajmire P, et al. Preparation and characterization of co-crystals of diacerein. Indonesian J Pharm. 2017;28(1):34.
   Web of Science ®Google Scholar
• Sun C, Grant DJ. Influence of crystal shape on the tableting performance of l‐lysine monohydrochloride dihydrate. J Pharm Sci. 2001;90(5):569–579.
   PubMed Web of Science ®Google Scholar
• Chow SF, Chen M, Shi L, et al. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide. Pharm Res. 2012;29(7):1854–1865.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, et al. Ddsolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263–271.
   PubMed Web of Science ®Google Scholar
• Laurence DR, Bacharach AL. Evaluation of drug activities: pharmacometrics. Amsterdam (The Netherlands): Elsevier; 1964.
   Google Scholar
• Jung MS, Kim JS, Kim MS, et al. Bioavailability of indomethacin‐saccharin cocrystals. J Pharm Pharmacol. 2010;62(11):1560–1568.
   PubMed Web of Science ®Google Scholar
• Shah SNH, Sohail K, Javaid Z, et al. Development and validation of rp-hplc method for determination of lornoxicam in rabbit’s plasma. PJPS. 2019;32:333–338.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, et al. Pksolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in microsoft excel. Comput Methods Programs Biomed. 2010;99(3):306–314.
   PubMed Web of Science ®Google Scholar
• Qiao N, Li M, Schlindwein W, et al. Pharmaceutical cocrystals: an overview. Int J Pharm. 2011;419(1–2):1–11.
   PubMed Web of Science ®Google Scholar
• Sunita S, Hosmani A. Preparation and evaluation of nanosuspensions for enhancing the dissolution of lornoxicam by antisolvent precipitation technique. Indo Am J Pharma Res. 2014;4:398–405.
   Google Scholar
• Kharisma RM, Sopyan I. Dissolution rate repairing of simvastatin as a new approach in cocrystallization. Der Pharm Lett. 2017;9:18–27.
   Google Scholar
• Samipillai M, Rohani S. The role of higher coformer stoichiometry ratio in pharmaceutical cocrystals for improving their solid-state properties: the cocrystals of progesterone and 4-hydroxybenzoic acid. J Cryst Growth. 2019;507:270–282.
   Web of Science ®Google Scholar
• Sopyan I, Fudholi A, Muchtaridi M, et al. Co-crystallization: a tool to enhance solubility and dissolution rate of simvastatin. J Young Pharm. 2017;9(2):183–186.
   Web of Science ®Google Scholar
• He Y, Majid K, Maqbool M, et al. Formulation and characterization of lornoxicam-loaded cellulosic-microsponge gel for possible applications in arthritis. Saudi Pharm J. 2020;28(8):994–1003.
   PubMed Web of Science ®Google Scholar
• Bansal AK, Pande V. Development and evaluation of dual cross-linked pulsatile beads for chronotherapy of rheumatoid arthritis. J Pharm. 2013;2013:906178.
   Google Scholar
• Tawfeek HM, Saleem IY, Roberts M. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets. J Pharm Sci. 2014;103(8):2470–2483.
   PubMed Web of Science ®Google Scholar
• Hamza YE-S, Aburahma MH. Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination. AAPS PharmSciTech. 2009;10(4):1357–1367.
   PubMed Web of Science ®Google Scholar
• Ammar HO, Ghorab M, Mahmoud AA, et al. Topical liquid crystalline gel containing lornoxicam/cyclodextrin complex. J Incl Phenom Macrocycl Chem. 2012;73(1–4):161–175.
   Web of Science ®Google Scholar
• Gawale D, Sonawane R, Pandey V, et al. Formulation and in vitro characterization of multiple unit sustained release matrix pellets of lornoxicam using natural gums. Indian J Novel Drug Deliv. 2013;5:208–220.
   Google Scholar
• Yamashita H, Hirakura Y, Yuda M, et al. Detection of cocrystal formation based on binary phase diagrams using thermal analysis. Pharm Res. 2013;30(1):70–80.
   PubMed Web of Science ®Google Scholar
• Karagianni A, Malamatari M, Kachrimanis K. Pharmaceutical cocrystals: new solid phase modification approaches for the formulation of apis. Pharmaceutics. 2018;10(1):18.
   Web of Science ®Google Scholar
• Yilgör E, Yurtsever E, Yilgör I. Hydrogen bonding and polyurethane morphology. Ii. Spectroscopic, thermal and crystallization behavior of polyether blends with 1,3-dimethylurea and a model urethane compound. Polymer. 2002;43(24):6561–6568.
   Web of Science ®Google Scholar
• Fule R, Meer T, Amin P, et al. Preparation and characterisation of lornoxicam solid dispersion systems using hot melt extrusion technique. Int J Pharm Investig. 2014;44(1):41–59.
   Google Scholar
• Guo Z, Liu X-M, Ma L, et al. Effects of particle morphology, pore size and surface coating of mesoporous silica on naproxen dissolution rate enhancement. Colloids Surf B Biointerfaces. 2013;101:228–235.
   PubMed Web of Science ®Google Scholar
• Latif S, Abbas N, Hussain A, et al. Development of paracetamol-caffeine co-crystals to improve compressional, formulation and in vivo performance. Drug Dev Ind Pharm. 2018;44(7):1099–1108.
   PubMed Web of Science ®Google Scholar
• Modi SR, Dantuluri AK, Perumalla SR, et al. Effect of crystal habit on intrinsic dissolution behavior of celecoxib due to differential wettability. Cryst Growth Des. 2014;14(10):5283–5292.
   Web of Science ®Google Scholar
• Serrano DR, O’Connell P, Paluch KJ, et al. Cocrystal habit engineering to improve drug dissolution and alter derived powder properties. J Pharm Pharmacol. 2016;68(5):665–677.
   PubMed Web of Science ®Google Scholar
• Ober CA, Gupta RB. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization. AAPS PharmSciTech. 2012;13(4):1396–1406.
   PubMed Web of Science ®Google Scholar
• Chattoraj S, Shi L, Sun CC. Understanding the relationship between crystal structure, plasticity and compaction behaviour of theophylline, methyl gallate, and their 1:1 co-crystal. CrystEngComm. 2010;12(8):2466–2472.
   Web of Science ®Google Scholar
• Karki S, Friščić T, Fábián L, et al. Improving mechanical properties of crystalline solids by cocrystal formation: new compressible forms of paracetamol. J Adv Mater. 2009;21(38–39):3905–3909.
   Google Scholar
• British Pharmacopoeia Commission. British pharmacopoeia. London (UK): BPC; 2016.
   Google Scholar
• Yuliandra Y, Zaini E, Syofyan S, et al. Cocrystal of ibuprofen–nicotinamide: solid-state characterization and in vivo analgesic activity evaluation. Sci Pharm. 2018;86(2):23.
   Web of Science ®Google Scholar
• Dressman JB, Reppas C. In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci. 2000;11:S73–S80.
   PubMed Web of Science ®Google Scholar
• Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des. 2009;9(6):2950–2967.
   PubMed Web of Science ®Google Scholar
• Bhalla Y, Chadha K, Chadha R, et al. Daidzein cocrystals: an opportunity to improve its biopharmaceutical parameters. Heliyon. 2019;5(11):e02669.
   PubMed Web of Science ®Google Scholar